Press Releases

For a full overview of our announcements and press releases, visit our Euronext Oslo Børs Newsweb

NewsWeb

Newest first
Oldest first

24/08/2018

QUARTERLY REPORT – 2018 Q2

14/05/2018

QUARTERLY REPORT – 2018 Q1

26/04/2018

VACCIBODY AS ANNOUNCES STRONG KILLER T CELL RESPONSES (CD8+) in VB10.16 VACCINATED PATIENTS FURTHER STRENGTHENING THE STRONG POTENTIAL OF THEIR VACCINE TECHNOLOGY PLATFORM; PRESENTING AT EUROPEAN NEOANTIGEN SUMMIT AMSTERDAM

04/04/2018

VACCIBODY AS ANNOUNCES INFORMED CONSENT SIGNED BY FIRST PATIENT AND ENROLMENT PROCESS INITIATED IN THE CANCER NEOANTIGEN PHASE I/IIA CLINICAL TRIAL.

03/04/2018

Vaccibody calls for Annual General Meeting.

Pages: 12345678910111213141516171819202122232425262728293031323334353637383940